Neuropharmacology & Neurodegeneration

submenu

Faculty in this group are conducting innovative research directed at mechanisms of neuronal function under normal conditions and in neurodegenerative diseases such as Alzheimer's disease.

Cannabinoids reverse synaptically driven synapse loss. For details, read Kim et al J. Pharmacol. Exp. Ther. 325:850-858

Cannabinoids reverse synaptically driven synapse loss.

Studies range from receptor function, calcium mobilization, cholesterol homeostasis and discovering new drug targets for treating neurodegenerative diseases. These faculty use novel imaging techniques, transgenic animal and cell models, biochemical, molecular biological and cellular approaches to understand mechanisms of normal and pathological neuronal function.

Faculty researching neuropharmacology and neurodegeneration: